Ontario Bioscience Innovation Organization – CAAP – Building Companies

ByMaurice

Description:

OBIO® Capital Access Advisory Program (CAAP®), a 9-month structured program for health science companies is designed to operate downstream from existing entrepreneurship programs and focuses on accelerating technology commercialization, working towards Series A financing and strategic partnerships. CAAP® covers three fundamental business themes:
1. Business strategic planning & increasing the ROI for investors;
2. Advanced fundraising strategies & financial modeling;
3. Closing an investment round.

Comments on Funding:

No funding provided.

Eligibility:

Applicants must be:

  • health science companies;
  • starting to raise Series A financing in Q4 2022 to 2023 timeframe.

Program Contact:

CAAP® — OBIO

About the author

Maurice

Maurice (Moe) Muise learned the ins-and-outs of government while an employee of the Government of Canada in Ottawa for 10 years. His current focus is helping small businesses in Ontario to identify and maximize government grants to grow their business. Click here to learn more about Moe’s background and how he can help your business.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *